
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE530CEA8AEE8FB3050CEA0055DC56BB.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361836/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of the Peripheral Nervous System">
<meta name="citation_title" content="Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape">
<meta name="citation_author" content="Luis Querol">
<meta name="citation_author_institution" content="Hospital de la Santa Creu i Sant Pau, Barcelona, Spain">
<meta name="citation_author" content="Simon Rinaldi">
<meta name="citation_author_institution" content="Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Andras Borsi">
<meta name="citation_author_institution" content="Janssen‐Cilag Ltd, A Johnson &amp; Johnson Company, High Wycombe, UK">
<meta name="citation_author" content="Giorgio Maria Boggia">
<meta name="citation_author_institution" content="Janssen‐Cilag SpA, A Johnson &amp; Johnson Company, Milan, Italy">
<meta name="citation_author" content="Jonathan de Courcy">
<meta name="citation_author_institution" content="Adelphi Real World, Bollington, UK">
<meta name="citation_author" content="Yasmin Taylor">
<meta name="citation_author_institution" content="Adelphi Real World, Bollington, UK">
<meta name="citation_author" content="Jack Wright">
<meta name="citation_author_institution" content="Adelphi Real World, Bollington, UK">
<meta name="citation_author" content="Wisam Karmous">
<meta name="citation_author_institution" content="Janssen‐Cilag, A Johnson &amp; Johnson Company, Strasbourg, France">
<meta name="citation_author" content="Wim Noel">
<meta name="citation_author_institution" content="Janssen Pharmaceutica NV, A Johnson &amp; Johnson Company, Beerse, Belgium">
<meta name="citation_author" content="Charlotte Gary">
<meta name="citation_author_institution" content="Janssen‐Cilag, A Johnson &amp; Johnson Company, Strasbourg, France">
<meta name="citation_author" content="Gerd Meyer zu Hörste">
<meta name="citation_author_institution" content="University Hospital Münster, Münster, Germany">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="30">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="e70047">
<meta name="citation_doi" content="10.1111/jns.70047">
<meta name="citation_pmid" content="40826893">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361836/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361836/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361836/pdf/JNS-30-0.pdf">
<meta name="description" content="Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune‐mediated syndrome characterized by progressive muscle weakness and sensory impairment. Clinical similarities with other neuropathies can cause misdiagnoses and delayed diagnoses. ...">
<meta name="og:title" content="Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune‐mediated syndrome characterized by progressive muscle weakness and sensory impairment. Clinical similarities with other neuropathies can cause misdiagnoses and delayed diagnoses. ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361836/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12361836">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/jns.70047"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/JNS-30-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12361836%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12361836/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12361836/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361836/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/jns.70047" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Peripher Nerv Syst</button></div>. 2025 Aug 18;30(3):e70047. doi: <a href="https://doi.org/10.1111/jns.70047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/jns.70047</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Peripher%20Nerv%20Syst%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Peripher%20Nerv%20Syst%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Peripher%20Nerv%20Syst%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Peripher%20Nerv%20Syst%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Querol%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Luis Querol</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Luis Querol</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Hospital de la Santa Creu i Sant Pau, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Querol%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Luis Querol</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rinaldi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Simon Rinaldi</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Simon Rinaldi</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rinaldi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Simon Rinaldi</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borsi%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Andras Borsi</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Andras Borsi</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Janssen‐Cilag Ltd, A Johnson &amp; Johnson Company, High Wycombe, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borsi%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andras Borsi</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boggia%20GM%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Giorgio Maria Boggia</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Giorgio Maria Boggia</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Janssen‐Cilag SpA, A Johnson &amp; Johnson Company, Milan, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boggia%20GM%22%5BAuthor%5D" class="usa-link"><span class="name western">Giorgio Maria Boggia</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Courcy%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jonathan de Courcy</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jonathan de Courcy</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Adelphi Real World, Bollington, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Courcy%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jonathan de Courcy</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Taylor%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Yasmin Taylor</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Yasmin Taylor</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Adelphi Real World, Bollington, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Taylor%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yasmin Taylor</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wright%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Jack Wright</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Jack Wright</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Adelphi Real World, Bollington, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wright%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jack Wright</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karmous%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Wisam Karmous</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Wisam Karmous</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Janssen‐Cilag, A Johnson &amp; Johnson Company, Strasbourg, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karmous%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wisam Karmous</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Noel%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Wim Noel</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Wim Noel</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>Janssen Pharmaceutica NV, A Johnson &amp; Johnson Company, Beerse, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Noel%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wim Noel</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gary%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Charlotte Gary</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Charlotte Gary</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Janssen‐Cilag, A Johnson &amp; Johnson Company, Strasbourg, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gary%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Charlotte Gary</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22zu%20H%C3%B6rste%20GM%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Gerd Meyer zu Hörste</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Gerd Meyer zu Hörste</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>University Hospital Münster, Münster, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22zu%20H%C3%B6rste%20GM%22%5BAuthor%5D" class="usa-link"><span class="name western">Gerd Meyer zu Hörste</span></a>
</div>
</div>
<sup>8</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="jns70047-aff-0001">
<sup>
<sup>1</sup>
</sup>Hospital de la Santa Creu i Sant Pau, Barcelona, Spain</div>
<div id="jns70047-aff-0002">
<sup>
<sup>2</sup>
</sup>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK</div>
<div id="jns70047-aff-0003">
<sup>
<sup>3</sup>
</sup>Janssen‐Cilag Ltd, A Johnson &amp; Johnson Company, High Wycombe, UK</div>
<div id="jns70047-aff-0004">
<sup>
<sup>4</sup>
</sup>Janssen‐Cilag SpA, A Johnson &amp; Johnson Company, Milan, Italy</div>
<div id="jns70047-aff-0005">
<sup>
<sup>5</sup>
</sup>Adelphi Real World, Bollington, UK</div>
<div id="jns70047-aff-0006">
<sup>
<sup>6</sup>
</sup>Janssen‐Cilag, A Johnson &amp; Johnson Company, Strasbourg, France</div>
<div id="jns70047-aff-0007">
<sup>
<sup>7</sup>
</sup>Janssen Pharmaceutica NV, A Johnson &amp; Johnson Company, Beerse, Belgium</div>
<div id="jns70047-aff-0008">
<sup>
<sup>8</sup>
</sup>University Hospital Münster, Münster, Germany</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Simon Rinaldi (<span>simon.rinaldi@nhs.net</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 23; Received 2025 May 19; Accepted 2025 Jul 31; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Journal of the Peripheral Nervous System</em> published by Wiley Periodicals LLC on behalf of Peripheral Nerve Society.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12361836  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40826893/" class="usa-link">40826893</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="jns70047-sec-0001"><h3 class="pmc_sec_title">Background and Aims</h3>
<p>Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune‐mediated syndrome characterized by progressive muscle weakness and sensory impairment. Clinical similarities with other neuropathies can cause misdiagnoses and delayed diagnoses. Additionally, a large proportion of patients appropriately treated according to current guidelines still show residual disability. This real‐world study aimed to characterize a global cohort of patients with CIDP.</p></section><section id="jns70047-sec-0002"><h3 class="pmc_sec_title">Methods</h3>
<p>Data were drawn from the Adelphi CIDP Disease Specific Programme, a cross‐sectional survey with retrospective data collection, conducted in China, France, Germany, Italy, Japan, Spain, the United Kingdom, and the United States between September 2022 and April 2023. Neurologists and neuromuscular specialists reported on patient demographic and clinical characteristics at the time of the survey. Patients self‐reported treatment satisfaction, disease control, and health‐related outcome measures.</p></section><section id="jns70047-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>Overall, 164 physicians provided data for 1056 patients, with 428 (40.5%) providing self‐reported data. Patients were diagnosed with typical CIDP (69.2%) and variant CIDP (30.8%). Overall, initial misdiagnosis occurred in 37.2% of patients, with a median (interquartile range) diagnostic delay of 6.0 (3.0–12.0) months. Maintenance therapy was prescribed for 81.6% of patients, with corticosteroid use ranging from 25.7% in the United States to 80.0% in China. Some patients were dissatisfied by treatment outcomes (11.0%) and symptom control (12.2%). Overall, mean (SD) patient‐reported scores were 62.1 (20.4) for I‐RODS, 35.0 (11.1) for FACIT fatigue, and 0.662 (0.253) for EQ‐5D‐5L.</p></section><section id="jns70047-sec-0004"><h3 class="pmc_sec_title">Interpretation</h3>
<p>Diagnostic delay and misdiagnoses were common occurrences across typical CIDP and variant CIDP. Despite the use of guideline treatments, there were unmet needs and a continued disease burden for patients.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> chronic inflammatory demyelinating polyneuropathy, disease burden, healthcare resource utilization, patient reported outcomes, treatment patterns</p></section></section><section id="jns70047-sec-0005"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most frequent form of chronic immune‐mediated polyneuropathy. Reported prevalences for CIDP show considerable regional variation, with an estimated range of 1–9 per 100 000 people [<a href="#jns70047-bib-0001" class="usa-link" aria-describedby="jns70047-bib-0001">1</a>]. CIDP is caused by primary immune‐mediated demyelination and secondary axonal damage in the peripheral nervous system, resulting in progressive muscle weakness and sensory impairment that led to significant disability [<a href="#jns70047-bib-0002" class="usa-link" aria-describedby="jns70047-bib-0002">2</a>]. CIDP can be delineated into typical CIDP, or a CIDP variant such as distal, multifocal, focal, motor, or sensory CIDP [<a href="#jns70047-bib-0003" class="usa-link" aria-describedby="jns70047-bib-0003">3</a>, <a href="#jns70047-bib-0004" class="usa-link" aria-describedby="jns70047-bib-0004">4</a>].</p>
<p>Even with published diagnostic guidelines available [<a href="#jns70047-bib-0005" class="usa-link" aria-describedby="jns70047-bib-0005">5</a>], delayed diagnosis and misdiagnoses are common due to the rarity of CIDP, clinical similarities with other neuropathies, a lack of diagnostic biomarkers, and clinical variation. A retrospective Dutch study showed a median (range) 9 (1–334) month diagnostic delay in patients diagnosed outside of the tertiary referral center, and a 24 (2–190) month delay for those referred to the tertiary center with another diagnosis [<a href="#jns70047-bib-0006" class="usa-link" aria-describedby="jns70047-bib-0006">6</a>]. Cross‐sectional quantitative survey data from neurologists in the US found a majority did not make use of published guidelines in the diagnosis or treatment of CIDP [<a href="#jns70047-bib-0007" class="usa-link" aria-describedby="jns70047-bib-0007">7</a>]. Patients who experience misdiagnosis may be inadvertently subject to unnecessary costly treatment, which can result in burdensome adverse events (AEs) [<a href="#jns70047-bib-0006" class="usa-link" aria-describedby="jns70047-bib-0006">6</a>, <a href="#jns70047-bib-0008" class="usa-link" aria-describedby="jns70047-bib-0008">8</a>, <a href="#jns70047-bib-0009" class="usa-link" aria-describedby="jns70047-bib-0009">9</a>].</p>
<p>First‐line treatment options for CIDP are intravenous immunoglobulin (IVIg), corticosteroids, and plasma exchange treatment (PLEX). First‐line IVIg compared to prednisolone has shown little or no differential effect on disability or frequency of serious AEs [<a href="#jns70047-bib-0010" class="usa-link" aria-describedby="jns70047-bib-0010">10</a>]; PLEX also likely has a similar short‐term effect on disability when compared to IVIg. Patients' refractory or not responding to first‐line treatments may receive immunosuppressive drugs (e.g., azathioprine, ciclosporin, mycophenolate mofetil) or escalation therapies such as cyclophosphamide or rituximab [<a href="#jns70047-bib-0005" class="usa-link" aria-describedby="jns70047-bib-0005">5</a>]. However, due to the uncertain benefit of these second‐line therapies and the possibility of AEs, their use must be carefully discussed between the patient and physician regarding potential outcomes [<a href="#jns70047-bib-0005" class="usa-link" aria-describedby="jns70047-bib-0005">5</a>, <a href="#jns70047-bib-0011" class="usa-link" aria-describedby="jns70047-bib-0011">11</a>]. Beyond this, novel treatment classes for CIDP, such as B‐cell inhibitors, complement inhibitors, and neonatal fragment crystallizable receptor (FcRn) blockers, are currently being investigated in clinical trials [<a href="#jns70047-bib-0012" class="usa-link" aria-describedby="jns70047-bib-0012">12</a>], with a FcRn blocker recently receiving US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approval for the treatment of CIDP in 2024 and 2025, respectively [<a href="#jns70047-bib-0013" class="usa-link" aria-describedby="jns70047-bib-0013">13</a>, <a href="#jns70047-bib-0014" class="usa-link" aria-describedby="jns70047-bib-0014">14</a>].</p>
<p>Due to its symptomatology, treatment options, and potential for misdiagnosis, CIDP is known to have a high physical and psychosocial burden [<a href="#jns70047-bib-0004" class="usa-link" aria-describedby="jns70047-bib-0004">4</a>]. Residual disability in patients with CIDP has been shown in several studies, with a recent meta‐analysis finding a majority of patients with long‐term CIDP still experiencing disability [<a href="#jns70047-bib-0015" class="usa-link" aria-describedby="jns70047-bib-0015">15</a>]. In a prospective Dutch cohort investigating clinical outcomes after 1 year of treatment, a majority of patients reported residual symptoms or deficits, irrespective of starting treatment [<a href="#jns70047-bib-0016" class="usa-link" aria-describedby="jns70047-bib-0016">16</a>]. Similar to this, a recent retrospective study on a UK cohort found residual disability in more than 60% of patients despite responding to treatment [<a href="#jns70047-bib-0017" class="usa-link" aria-describedby="jns70047-bib-0017">17</a>].</p>
<p>There is a lack of evidence assessing the treatment needs and burden of patients with CIDP from both the physician and patient perspective in a real‐world scenario. Additionally, there is limited data comparing patient and physician reported treatment satisfaction and disease control. This real‐world analysis aimed to characterize a global cohort of patients with CIDP and to identify unmet needs among them.</p></section><section id="jns70047-sec-0006"><h2 class="pmc_sec_title">2. Methods and Materials</h2>
<section id="jns70047-sec-0007"><h3 class="pmc_sec_title">2.1. Study Design</h3>
<p>This study was a secondary analysis of data drawn from the Adelphi Real World CIDP Disease Specific Programme (DSP), a cross‐sectional survey with elements of retrospective data collection, conducted in China, Europe (France, Germany, Italy, Spain, UK), Japan, and the USA between September 2022 and April 2023.</p>
<p>DSPs are surveys of physicians and their patients who present in a real‐world clinical setting and collect data on current disease management, disease‐burden impact, and associated treatment effects, using both clinical measures and the perspective of physicians and their patients. The DSP methodology has been previously described [<a href="#jns70047-bib-0018" class="usa-link" aria-describedby="jns70047-bib-0018">18</a>], validated [<a href="#jns70047-bib-0019" class="usa-link" aria-describedby="jns70047-bib-0019">19</a>], and demonstrated to be representative and consistent over time [<a href="#jns70047-bib-0020" class="usa-link" aria-describedby="jns70047-bib-0020">20</a>], countries, and disease areas, such as neurology [<a href="#jns70047-bib-0021" class="usa-link" aria-describedby="jns70047-bib-0021">21</a>].</p></section><section id="jns70047-sec-0008"><h3 class="pmc_sec_title">2.2. Study Eligibility</h3>
<p>Neurologists and neuromuscular specialists were recruited to participate in the DSP by local fieldwork agents, following completion of a short screening questionnaire. Physicians were eligible to participate in this survey if they were personally responsible for treatment decisions and management of patients with CIDP. It should be noted that neurologists can specialize in treating CIDP without becoming neuromuscular specialists, and that the neuromuscular specialist role is not universal across all countries. Physician participation was financially incentivized, with reimbursement upon survey completion according to fair market value.</p>
<p>Physicians were instructed to complete a patient record form for up to 10 eligible consecutively consulting patients who visited them for routine care, to mitigate against selection bias and to provide a patient sample representative of those presenting in a real‐world clinical setting. Patients were eligible for inclusion in the survey if they were 18 or older, had a physician‐confirmed diagnosis of CIDP, and visited the physician for consultation. Specified diagnostic criteria did not form part of this survey, and physician‐confirmed diagnoses did not undergo additional validation. However, the tests and assessments that were conducted to aid in patient CIDP diagnoses are given in the supplementary information. Record forms were completed at the time of their most recent consultation, collecting cross‐sectional data as well as retrospective information derived from historical clinical records.</p></section><section id="jns70047-sec-0009"><h3 class="pmc_sec_title">2.3. Physician‐Reported Data</h3>
<p>Upon recruitment, physicians completed an attitudinal survey to investigate their specialty and level of experience, practice setting, treatment practices, and perceptions about CIDP management.</p>
<p>The patient record form contained detailed questions on clinical and demographic characteristics, including symptomatic burden, CIDP variant, diagnostic delay (defined as time from symptom onset to physician confirmed diagnosis of CIDP), misdiagnosis, treatment patterns, and outcome satisfaction, and disease control, which was answered based on the physician's experience and clinical judgment. Comorbidities, such as anxiety and depression, could be selected from a predefined list from the Charlson comorbidities index; however, information on how they were defined or diagnosed was not part of the survey. Disease severity was measured using the Inflammatory Neuropathy Cause and Treatment (INCAT) Disability Score, where arm and leg problems were both scored 0–5 to give a total 0–10 score, spanning no disability to complete functional loss [<a href="#jns70047-bib-0022" class="usa-link" aria-describedby="jns70047-bib-0022">22</a>].</p>
<p>Patient record forms were completed with reference to patient clinical records to mitigate recall bias. This survey was designed to facilitate understanding of real‐world clinical practice, and thus physicians completed questions using their own clinical judgment and data they had to hand at the time of the consultation, representing the evidence available when making management decisions at that consultation. No additional diagnostic procedures, treatments, or other investigations were performed as part of this survey. Upon record form completion, physicians were compensated for participation according to fair market rates.</p></section><section id="jns70047-sec-0010"><h3 class="pmc_sec_title">2.4. Patient‐Reported Data</h3>
<p>Each patient for whom the physician completed a record form was invited to voluntarily complete a patient self‐reported questionnaire. Patient self‐reported questionnaires were completed by the patient independently from their physician and were returned in a sealed envelope, ensuring the patient's responses were kept confidential from their physician.</p>
<p>Patient‐reported questionnaires contained detailed questions including treatment satisfaction, disease control, as well as several patient‐reported outcome measures (PROMs). Patients were not compensated for participation.</p></section><section id="jns70047-sec-0011"><h3 class="pmc_sec_title">2.5. Patient Reported Outcome Measures</h3>
<p>Several measures were used to assess the outcomes of patients diagnosed with CIDP. Patient‐reported level of disability was measured using the Inflammatory Rasch‐built Overall Disability Scale (I‐RODS) [<a href="#jns70047-bib-0023" class="usa-link" aria-describedby="jns70047-bib-0023">23</a>]. In this study, scores were reported as centiles, with higher scores indicating lesser disability.</p>
<p>The 13‐item fatigue subscale of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system (Version 4.0) [<a href="#jns70047-bib-0024" class="usa-link" aria-describedby="jns70047-bib-0024">24</a>] provided a score for health‐related quality of life (HRQoL) in relation to fatigue. Higher scores indicate less fatigue and its subsequent impact upon daily activities, with a score range of 0 to 52. Scores of ≤ 21 were considered indicative of severe fatigue [<a href="#jns70047-bib-0025" class="usa-link" aria-describedby="jns70047-bib-0025">25</a>].</p>
<p>The EuroQol–5 dimension–5 level (EQ‐5D‐5L) health utility system was used to assess patients generic HRQoL [<a href="#jns70047-bib-0026" class="usa-link" aria-describedby="jns70047-bib-0026">26</a>, <a href="#jns70047-bib-0027" class="usa-link" aria-describedby="jns70047-bib-0027">27</a>]. In line with guidance from the National Institute for Health and Care Excellence (NICE) [<a href="#jns70047-bib-0028" class="usa-link" aria-describedby="jns70047-bib-0028">28</a>], the study calculated utility values by mapping the 5 L descriptive system data onto the 3 L using the Hernandez‐Alava UK value set [<a href="#jns70047-bib-0029" class="usa-link" aria-describedby="jns70047-bib-0029">29</a>, <a href="#jns70047-bib-0030" class="usa-link" aria-describedby="jns70047-bib-0030">30</a>]. These scores exist in the range of &lt; 0 (worse than death), 0 (death) and 1 (perfect health) [<a href="#jns70047-bib-0029" class="usa-link" aria-describedby="jns70047-bib-0029">29</a>].</p></section><section id="jns70047-sec-0012"><h3 class="pmc_sec_title">2.6. Ethical Considerations</h3>
<p>Patients provided their informed consent to take part in the survey, and no identifiable protected health information was collected during the course of the survey. Data were anonymized and aggregated before being shared with the study team and/or for analysis and publication, thus collected in such a way that patients and physicians could not be identified directly.</p>
<p>Data collection was undertaken in line with European Pharmaceutical Marketing Research Association guidelines and, as such, did not require ethics committee approval [<a href="#jns70047-bib-0031" class="usa-link" aria-describedby="jns70047-bib-0031">31</a>]. The survey materials were submitted and reviewed by the PEARL International Review Board (IRB) (protocol #22‐ADRW‐153) and were approved for exempt research determination in accordance with the applicable federal regulations from approval.</p>
<p>In addition, each survey was performed in full accordance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act 1996 [<a href="#jns70047-bib-0032" class="usa-link" aria-describedby="jns70047-bib-0032">32</a>] and Health Information Technology for Economic and Clinical Health Act legislation [<a href="#jns70047-bib-0033" class="usa-link" aria-describedby="jns70047-bib-0033">33</a>].</p></section><section id="jns70047-sec-0013"><h3 class="pmc_sec_title">2.7. Data Analysis</h3>
<p>Descriptive analysis was performed on data from all study countries and/or the Europe region. Means and standard deviations, or medians and interquartile ranges, were calculated for continuous variables, and frequency counts and percentages for categorical variables.</p>
<p>All analyses were conducted in UNICOM Intelligence Reporter version 7.5.1 (UNICOM Systems 2021). Missing data were not imputed; therefore, the base of patients for analysis could vary from variable to variable and was reported separately for each analysis.</p></section></section><section id="jns70047-sec-0014"><h2 class="pmc_sec_title">3. Results</h2>
<section id="jns70047-sec-0015"><h3 class="pmc_sec_title">3.1. Study Population</h3>
<p>Overall, 164 neurologists completed patient record forms for 1056 of their consulting adult patients with CIDP. Of these patients, 428 (40.5%) completed the voluntary patient‐reported questionnaire.</p>
<p>Of the participating physicians, 82.1% were general neurologists and 17.9% had the specific title of neuromuscular specialist. Overall, physicians reported that they managed a median (IQR) of 20 (10–50) adult patients with CIDP each over the past 12 months prior to data collection. According to physicians' typical caseload, patients were consulted in either a public (hospital: 54.2%; office: 13.7%) or private setting (hospital: 14.0%; office: 18.0%). In addition, 65.2% reported spending at least some of their time on academic/teaching duties.</p></section><section id="jns70047-sec-0016"><h3 class="pmc_sec_title">3.2. Patient Demographics and Clinical Characteristics in Accordance With Expectations</h3>
<p>Data for patient demographics in Europe (<em>n</em> = 542, 51.3%), US (<em>n</em> = 291, 27.6%), China (<em>n</em> = 120, 11.4%), and Japan (<em>n</em> = 103, 9.8%) are shown in Table <a href="#jns70047-tbl-0001" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="jns70047-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Patient demographics &amp; clinical characteristics split by region/country.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">All patients, (<em>n</em> = 1056)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Europe, (<em>n</em> = 542)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">US, (<em>n</em> = 291)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">China, (<em>n</em> = 120)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Japan, (<em>n</em> = 103)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age (years), mean (SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.0 (13.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.0 (12.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.5 (12.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47.4 (13.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">59.8 (14.5)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sex (male), <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">654 (61.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">337 (62.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">181 (62.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">66 (55.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">70 (68.0%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>), mean (SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.8 (3.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25.1 (3.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.0 (3.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.9 (2.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.5 (3.3)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Number of concomitant conditions<a href="#jns70047-note-0003" class="usa-link">
<sup>a</sup>
</a>, mean (SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.9 (1.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.8 (1.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.1 (1.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0 (1.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.6 (0.8)</td>
</tr>
<tr><td align="left" colspan="6" valign="top" rowspan="1">Comorbidities, <em>n</em> (%)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">None shown</td>
<td align="center" valign="top" rowspan="1" colspan="1">474 (44.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">271 (50.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">101 (34.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49 (40.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">53 (51.5%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Anxiety</td>
<td align="center" valign="top" rowspan="1" colspan="1">140 (13.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">71 (13.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">61 (21.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (6.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Depression</td>
<td align="center" valign="top" rowspan="1" colspan="1">137 (13.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">72 (13.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">56 (19.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (3.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (4.9%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">INCAT, median (IQR)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 (2.0–5.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 (2.0–4.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 (2.0–5.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.0 (2.0–5.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 (1.0–5.0)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jns70047-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jns70047-note-0002"><p>Abbreviations: BMI, Body mass index; INCAT, Inflammatory Neuropathy Cause and Treatment; IQR, interquartile range; SD, Standard deviation.</p></div>
<div class="fn" id="jns70047-note-0003">
<sup>
<sup>a</sup>
</sup><p class="display-inline">The choices given to physicians for specific concomitant conditions also included: diabetes without chronic complications, chronic pulmonary disease, rheumatologic disease, peptic ulcer disease, mild liver disease, peripheral vascular disease, cerebrovascular disease, myocardial infarction, renal disease, monoclonal gammopathy (MGUS), congestive heart failure, diabetes with chronic complications, any malignancy, including leukemia and lymphoma, dementia, hemiplegia or paraplegia, metastatic solid tumor, long‐term effects of covid, moderate or severe liver disease, AIDS/HIV, and other.</p>
</div>
</div></section><p>Overall, at the time of the survey, the mean (SD) patient age was 54.0 (13.0) years, and 61.9% of patients were male, which ranged from 47.4 (13.9) years and 55.0% male in China to 59.8 (14.5) years and 68.0% male in Japan. Patients had a mean BMI of 24.8 (3.5), which ranged from 22.5 (3.3) in Japan to 26.0 (3.7) in the US (Table <a href="#jns70047-tbl-0001" class="usa-link">1</a>). At the time of the survey, patients had a median (IQR) disease duration of 3.3 (1.7–6.0) years.</p>
<p>The average number of concomitant conditions in patients was 0.9 (1.1), with anxiety reported at 13.3%, followed by depression at 13.0%. For the overall cohort, 55.1% had at least one concomitant condition, ranging from 65.3% in the US to 48.5% in Japan (Table <a href="#jns70047-tbl-0001" class="usa-link">1</a>).</p>
<p>A majority of patients were diagnosed with typical CIDP (69.2%). The most commonly reported variant overall was multifocal CIDP at 8.4% (Figure <a href="#jns70047-fig-0001" class="usa-link">1a</a>). Between CIDP variants, there was variation in the distribution of INCAT scores. The proportions of those with a score of 3 or more ranged from 35.7% in sensory CIDP to 70.8% in multifocal CIDP. For a score of 6 or more, the range was 3.6% in sensory CIDP to 24.7% in motor CIDP (Figure <a href="#jns70047-fig-0001" class="usa-link">1b</a>).</p>
<figure class="fig xbox font-sm" id="jns70047-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e4/12361836/6acc8d904234/JNS-30-0-g007.jpg" loading="lazy" id="jats-graphic-1" height="305" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/jns70047-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(a) frequency of CIDP variants within the overall patient sample; (b) distribution of INCAT scores across CIDP variants. Abbreviations: CIDP—Chronic inflammatory demyelinating polyneuropathy, INCAT—Inflammatory Neuropathy Cause and Treatment. <sup>1</sup>The INCAT disability score, where 0 represents no disability and 10 represents complete functional loss.</p></figcaption></figure><p>For symptoms experienced as an overall cohort, peripheral numbness was the most commonly reported at 70.5%, ranging from 67.4% in the US to 79.6% in Japan. The following two commonly reported symptoms had larger ranges between regions, with distal muscle weakness ranging from 42.3% in the US to 75.7% in Japan, and peripheral tingling ranging from 21.7% in China to 64.4% in Europe (Supplementary Table <a href="#jns70047-supitem-0001" class="usa-link">1</a>).</p></section><section id="jns70047-sec-0017"><h3 class="pmc_sec_title">3.3. Diagnostic Journey Was Lengthy in Many Patients</h3>
<p>Overall, 37.2% of patients were initially misdiagnosed or suspected to have another condition based on symptoms that were later attributed to CIDP. Between CIDP types, 35.6% with typical CIDP were initially misdiagnosed, and for those with variant CIDP, initial misdiagnosis ranged from 36.5% in motor CIDP to 44.0% in multifocal CIDP (Table <a href="#jns70047-tbl-0002" class="usa-link">2</a>). When Guillain‐Barré syndrome (GBS) was excluded, initial misdiagnosis for patients with typical CIDP occurred in 28.5%; and between variant CIDP, this ranged from 26.0% in typical CIDP to 36.8% in multifocal CIDP. Across all patients, the median (IQR) diagnostic delay was 6.0 (3.0–12.0) months, which ranged from 4.5 (2.0–14.2) months in motor CIDP to 8.0 (3.2–10.0) months in focal CIDP. The second longest reported diagnostic delay was multifocal CIDP at 7.7 (4.3–24.4) months (Table <a href="#jns70047-tbl-0002" class="usa-link">2</a>). The median diagnostic delay along with the 5th, 25th, 75th, and 95th percentiles, between CIDP variants are shown in Figure <a href="#jns70047-fig-0002" class="usa-link">2</a>.</p>
<section class="tw xbox font-sm" id="jns70047-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Diagnostic journey split by CIDP variant.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">All patients</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Typical CIDP</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Distal CIDP</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Multifocal CIDP</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Focal CIDP</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Motor CIDP</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Sensory CIDP</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diagnostic delay (months)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 852</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 620</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 56</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 73</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 21</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 41</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 41</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Median (IQR)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.0 (3.0–12.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.0 (3.0–11.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.3 (3.6–14.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.7 (4.3–24.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.0 (3.2–10.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.5 (2.0–14.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.0 (3.7–16.7)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Initial misdiagnosis</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 854</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 599</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 56</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 75</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 19</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 63</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 42</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">318 (37.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">213 (35.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">24 (42.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">33 (44.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (36.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (36.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (42.9%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Condition(s) misdiagnosed<a href="#jns70047-note-0006" class="usa-link">
<sup>a</sup>
</a>, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 303</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 204</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 22</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 32</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 6</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 21</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 18</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Guillain‐Barré syndrome (GBS)</td>
<td align="center" valign="top" rowspan="1" colspan="1">87 (28.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">63 (30.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (27.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (21.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (28.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (27.8%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diabetic polyneuropathy</td>
<td align="center" valign="top" rowspan="1" colspan="1">43 (14.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">32 (15.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (13.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (3.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (16.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (19.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11.1%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Multiple Sclerosis (MS)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (11.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 (12.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (9.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (6.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (14.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (22.2%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Fibromyalgia</td>
<td align="center" valign="top" rowspan="1" colspan="1">31 (10.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 (9.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (4.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (3.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (19.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (27.8%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Toxic neuropathy</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (5.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (6.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (4.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (6.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (4.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (5.6%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jns70047-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jns70047-note-0004"><p>
<em>Note:</em> Diagnostic delay: defined as time from symptom onset to physician confirmed diagnosis of CIDP; Misdiagnosis: defined as initially diagnosed or suspected to have another condition responsible for symptoms that were later attributed to CIDP.</p></div>
<div class="fn" id="jns70047-note-0005"><p>Abbreviations: CIDP—Chronic inflammatory demyelinating polyneuropathy, IQR—Interquartile range.</p></div>
<div class="fn" id="jns70047-note-0006">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Other conditions misdiagnosed prior to confirmatory CIDP diagnosis included: amyotrophic lateral sclerosis (ALS), carpal tunnel syndrome, cerebral infarction, cervical spondylosis, diabetes complications, hereditary motor sensory neuropathy (HMSN), idiopathic polyneuropathy, lumbar disc herniation, lumbar spinal stenosis, lumbar spondylosis, Lyme disease, multifocal motor neuropathy (MMN), neuropathy, paraproteinemic neuropathy (PPN), peripheral nerve injury, peripheral neuropathy/neuritis, radiculopathy, rheumatoid arthritis, and other.</p>
</div>
</div></section><figure class="fig xbox font-sm" id="jns70047-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e4/12361836/0a69594c1b28/JNS-30-0-g001.jpg" loading="lazy" id="jats-graphic-3" height="295" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/jns70047-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Diagnostic delay (months from symptom onset to diagnosis of CIDP) experienced by patients across CIDP variants. Abbreviations: CIDP—Chronic inflammatory demyelinating polyneuropathy. Diagnostic delay: Defined as time from symptom onset to physician‐confirmed diagnosis of CIDP.</p></figcaption></figure><p>The most frequently reported conditions that formed a misdiagnosis, or were initially suspected to be causing patient symptoms, for all CIDP patients were GBS followed by diabetic polyneuropathy at 28.7% and 14.2%, respectively. Across all variants, aside from focal CIDP, GBS was ranked as the most reported misdiagnosed condition (Table <a href="#jns70047-tbl-0002" class="usa-link">2</a>). When GBS was excluded, the most frequently reported misdiagnosis or suspected condition was diabetic polyneuropathy (18.9%).</p>
<p>The majority of confirmatory CIDP diagnoses were made by a general neurologist for 78.2% of patients, ranging from 74.6% in Europe to 91.7% in Japan. Neuromuscular specialists were the diagnosing physicians for 21.2% of patients, ranging from 7.5% in China to 24.4% in Europe and the US. Less than 1% of patients were diagnosed by another healthcare professional (Supplementary Table <a href="#jns70047-supitem-0002" class="usa-link">2</a>).</p>
<p>The mean (SD) number of tests conducted to diagnose CIDP was 19.0 (9.8). Neurological examination was conducted in most patients (95.2%) to aid CIDP diagnosis. Overall, electromyograms and/or nerve conduction studies, nerve biopsies, and nerve ultrasound were used in the diagnosis of 90.8%, 17.7%, and 17.0% of patients, respectively. MRI and lumbar puncture/CSF testing were utilized in diagnosis for 53.9% and 63.6%, respectively (Supplementary Table <a href="#jns70047-supitem-0002" class="usa-link">2</a>).</p></section><section id="jns70047-sec-0018"><h3 class="pmc_sec_title">3.4. Treatment History Featured High Complexity in CIDP Patients</h3>
<p>Patients' treatment status at the time of the survey is shown in Figure <a href="#jns70047-fig-0003" class="usa-link">3a</a>. Maintenance therapy was prescribed for 81.6% of all patients at the time of the survey. In Europe, this was reported as 85.4%. In the US, China, and Japan, this was 73.5%, 91.7%, and 72.8%, respectively. Around a fifth (18.3%) of patients were not prescribed maintenance therapy at the time of the survey. The most common reason for patients to not be prescribed maintenance therapy was that their condition was stable without treatment, followed by the patient not wanting medication for their CIDP.</p>
<figure class="fig xbox font-sm" id="jns70047-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e4/12361836/df8411e5f25b/JNS-30-0-g003.jpg" loading="lazy" id="jats-graphic-5" height="300" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/jns70047-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(a) patient maintenance treatment (MT) status at the time of the survey; (b) frequency of prescribed therapies among those receiving MT; (c) mean (SD) and frequency of lines of MT received; among the overall patient sample and across regions. Abbreviations: MT—Maintenance therapy, SD—Standard deviation. Due to 1 decimal place rounding, percentages do not total exactly 100% in 3a. Other maintenance treatments included: amifampridine, amitriptyline, carbamazepine, duloxetine, gabapentin, pregabalin, venlafaxine, other.</p></figcaption></figure><p>Among all patients, 55.7% were prescribed immunoglobulins (IV/SCIg) and 44.5% corticosteroids at the time of the survey. IV/SCIg prescription ranged from 45.5% in China to 66.8% in the US. Corticosteroid prescription ranged from 25.7% in the US to 80.0% in China. For the total cohort, there were only 14 reported uses of plasma exchange therapy. Non‐steroidal immunosuppressants, monoclonal antibodies, and other treatments, such as neuropathic pain therapies, were prescribed to 33.6% of patients (Figure <a href="#jns70047-fig-0003" class="usa-link">3b</a>).</p>
<p>The majority of patients were prescribed a monotherapy; however, 31.2% of patients were prescribed more than one treatment at the time of data collection, ranging from 17.3% in Japan to 64.5% in China (Supplementary Table <a href="#jns70047-supitem-0002" class="usa-link">2</a>). For the overall patient cohort, it was reported that 60.2% of patients had received one line of therapy, 25.4% had received two lines, and 6.1% had received between 3 and 5 lines. There were also 88 (8.3%) patients that had no reported lines of therapy. The mean (SD) number of therapy lines was 1.3 (0.8), and in China it was 1.6 (0.8). The proportion of patients that received two lines of therapy ranged from 17.9% in the US to 35.8% in China (Figure <a href="#jns70047-fig-0003" class="usa-link">3c</a>).</p></section><section id="jns70047-sec-0019"><h3 class="pmc_sec_title">3.5. Physician and Patient Treatment and Symptom Control Satisfaction Was Limited in a Third of Patients</h3>
<p>For the overall physician cohort, 82.7% reported that they were satisfied (“very satisfied” or “somewhat satisfied”) and 4.9% dissatisfied (“somewhat dissatisfied” or “very dissatisfied”) with treatment outcomes. Symptom control achieved by treatment was considered well controlled (“very well controlled” or “well controlled”) by 72.2% of physicians and having poor control (“poorly controlled” or “very poorly controlled”) by 6.2% of physicians (Supplementary Table <a href="#jns70047-supitem-0003" class="usa-link">3</a>).</p>
<p>Among matched physician‐patient dyads, overall, 78.0% of physicians and 64.6% of patients reported that they were satisfied (“very satisfied” or “somewhat satisfied”) with treatment outcomes. Dissatisfaction (“somewhat dissatisfied” or “very dissatisfied”) with treatment outcomes were reported by 6.3% of physicians, and 11.0% of patients. These overall treatment satisfactions were reflected similarly in each region/country (Figure <a href="#jns70047-fig-0004" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="jns70047-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e4/12361836/25308b568701/JNS-30-0-g005.jpg" loading="lazy" id="jats-graphic-7" height="293" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/jns70047-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overall satisfaction with current drug treatment, reported by matched physician‐patient dyads and split by region/country.</p></figcaption></figure><p>Overall, matched physician and patient reported levels of symptom control achieved by treatment were also recorded. Symptoms were considered well controlled (“very well controlled” or “well controlled”) by 69.9% of physicians and 64.9% of patients. For poor symptom control (“poorly controlled” or “very poorly controlled”), this was reported by 5.8% of physicians and 12.2% of patients. (Figure <a href="#jns70047-fig-0005" class="usa-link">5</a>).</p>
<figure class="fig xbox font-sm" id="jns70047-fig-0005"><h4 class="obj_head">FIGURE 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e4/12361836/a7819552095a/JNS-30-0-g004.jpg" loading="lazy" id="jats-graphic-9" height="293" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/jns70047-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Perceived level of symptom control on current drug treatment, reported by matched physician‐patient dyads and split by region/country.</p></figcaption></figure></section><section id="jns70047-sec-0020"><h3 class="pmc_sec_title">3.6. Health Care Resource Utilization Was Moderately High</h3>
<p>The top three most reported health care professionals (HCPs) involved in patient management were general neurologists (83.5%), followed by physical therapists (37.8%) and family doctor/general practitioner/primary care physician (34.5%). In China, 100% of patients were reported to have received care management from general neurologists, 16.7% from neuromuscular specialists, 12.5% from physical therapists, and 5.0% from family doctor/general practitioner/primary care physician (Figure <a href="#jns70047-fig-0006" class="usa-link">6a</a> and Supplementary Table <a href="#jns70047-supitem-0004" class="usa-link">4</a>). A mean (SD) of 2.4 (1.4) HCPs were involved in patient management; in the 12 months prior to the survey, patients had a mean of 7.7 (12.7) HCP consultations (Figure <a href="#jns70047-fig-0006" class="usa-link">6b,c</a>).</p>
<figure class="fig xbox font-sm" id="jns70047-fig-0006"><h4 class="obj_head">FIGURE 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e4/12361836/be2dbfbdc40a/JNS-30-0-g006.jpg" loading="lazy" id="jats-graphic-11" height="300" width="709" alt="FIGURE 6"></p>
<div class="p text-right font-secondary"><a href="figure/jns70047-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Health care resource utilization, a) frequency of HCP involvement in patient management (five most frequently involved HCPs shown); b) mean (SD) total HCP types involved in patient management; c) mean (SD) total HCP consultations in the 12 months prior to survey; d) mobility aid utilization (five most frequently utilized devices shown); e) percentage of patients with one or more hospitalization in relation to CIDP in the 12 months prior to survey; f) percentage of patients with one or more ER admissions in the 12 months prior to survey. Abbreviations: ER—Emergency room, GP—General practitioner, HCP—Health care professional, PCP—Primary care physician, SD—Standard deviation. HCPs that were involved in less than 10% of all patient management included: nurse, internal medicine/internist, rehabilitation therapist, psychologist, psychiatrist, ophthalmologist, physician associate/assistant, speech and language therapist, neuropsychiatrist, and other. Mobility aids that were utilized by fewer than 2% of all patients included: Modified car (e.g., wheelchair accessible vehicle), motorized scooter, and other.</p></figcaption></figure><p>Overall, 47.3% of patients with CIDP (ranging from 41.7% in Japan and 50.0% in China) were recorded to use mobility aids at the time of data collection. Across all regions, a cane/walking stick was used by 35.3% of patients, followed by the wheeled walker (8.0%), walking frame, and/or manual wheelchair (both 4.9%) (Figure <a href="#jns70047-fig-0006" class="usa-link">6d</a>
<strong>and</strong> Supplementary Table <a href="#jns70047-supitem-0004" class="usa-link">4</a>).</p>
<p>Most patients (79.9%) did not have any hospitalizations in the 12 months prior to the time of survey. Over a tenth of patients (12.8%) had one hospitalization due to their CIDP, exclusive of treatment, and 7.5% had two or more hospitalizations. This was not shared by patients in China, where 27.0% were reported to have had no hospitalizations, and a proportion of single, double, and triple hospitalizations at 34.8%, 19.1%, and 13.5%, respectively (Figure <a href="#jns70047-fig-0006" class="usa-link">6e</a> and Supplementary Table <a href="#jns70047-supitem-0004" class="usa-link">4</a>). Overall, 92.3% of patients did not have any ER admissions in the 12 months prior to the time of survey. The proportions for the number of ER admissions for patients in China were within the range of all patients (Figure <a href="#jns70047-fig-0006" class="usa-link">6f</a>).</p></section><section id="jns70047-sec-0021"><h3 class="pmc_sec_title">3.7. Patient Reported Outcome Measures Reflect High Disease Burden</h3>
<p>The median (IQR) INCAT among the sample of patients with patient‐reported data was 2.0 (2.0–4.0), comparable to that observed among the overall sample.</p>
<p>This cohort reported a wide distribution of I‐RODS centile scores, with the mean (SD) score as 62.1 (20.4). The proportion of patients within each I‐RODS centile ranged from 22.1% between 60–69 and 0.3% between 10 and 19. There were no patients between the centile 0–9. In the 100th percentile, there were 11.6%, indicative of no disability (Figure <a href="#jns70047-fig-0007" class="usa-link">7a</a>).</p>
<figure class="fig xbox font-sm" id="jns70047-fig-0007"><h4 class="obj_head">FIGURE 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e4/12361836/b9683049bb51/JNS-30-0-g002.jpg" loading="lazy" id="jats-graphic-13" height="934" width="709" alt="FIGURE 7"></p>
<div class="p text-right font-secondary"><a href="figure/jns70047-fig-0007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(a) Distribution of I‐RODS centile scores; (b) Distribution of FACIT‐Fatigue scores; (c) Distribution of EQ‐5D health utility values, and frequency of response levels to individual dimensions. FACIT—Functional Assessment of Chronic Illness Therapy. I‐RODS—Inflammatory Rasch‐built Overall Disability Scale. I‐RODS data has been presented as centiles, with higher centile scores indicating lower disability. For FACIT‐Fatigue, higher scores indicate lesser fatigue. The EQ‐5D‐5L health utility values can exist in the range of &lt; 0 (worse than death), 0 (death) and 1 (perfect health).</p></figcaption></figure><p>For all patients, the mean (SD) FACIT fatigue score was 35.0 (11.1). The majority of patients (52.7%) had scores between 36 and 51. Around one in ten (10.6%) scored between 0 and 19, indicative of severe fatigue (Figure <a href="#jns70047-fig-0007" class="usa-link">7b</a>).</p>
<p>Overall, the mean (SD) EQ‐5D‐5L health utility score was 0.662 (0.253). The minimum–maximum range of patient scores was −0.225 to 0.989. Between individual EQ‐5D‐5L domains, there were similar response frequencies. Only self‐care had no issues (none) as a majority of responses (50.6%). In mobility and usual activities, 33.4% and 33.5%, respectively, had moderate to extreme issues (Figure <a href="#jns70047-fig-0007" class="usa-link">7c</a>).</p></section></section><section id="jns70047-sec-0022"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>We report on an international cohort of patients diagnosed with typical CIDP or variant CIDP. Overall, our data show that initial misdiagnoses for patients with CIDP remain a frequent occurrence. Additionally, even with roughly 80% of patients in our sample on maintenance therapy (mostly immunoglobulins and/or corticosteroids) at the time of survey, patient self‐reported data indicate the presence of residual disability.</p>
<p>Our cohort was the majority male, and most had at least one comorbidity, which aligns with previous studies [<a href="#jns70047-bib-0005" class="usa-link" aria-describedby="jns70047-bib-0005">5</a>, <a href="#jns70047-bib-0034" class="usa-link" aria-describedby="jns70047-bib-0034">34</a>]. In relation to variants of CIDP, we found 69.2% had typical CIDP and 30.8% had variant CIDP, with proportions consistent with a recent meta‐analysis, which reported the rate of typical CIDP as 62% [<a href="#jns70047-bib-0015" class="usa-link" aria-describedby="jns70047-bib-0015">15</a>].</p>
<p>Initial misdiagnosis was common in both typical and variant CIDP, with our data showing frequent misdiagnosis in CIDP variants, consistent with current reporting [<a href="#jns70047-bib-0005" class="usa-link" aria-describedby="jns70047-bib-0005">5</a>, <a href="#jns70047-bib-0009" class="usa-link" aria-describedby="jns70047-bib-0009">9</a>]. For our cohort overall, the total rate of misdiagnosis was more than a third, with GBS as the single most common misdiagnosis. In two single center studies, absolute rates of CIDP misdiagnosis ranged from 68% to 32%, and showed differing rates of GBS misdiagnosis, from 23% to 6% [<a href="#jns70047-bib-0006" class="usa-link" aria-describedby="jns70047-bib-0006">6</a>, <a href="#jns70047-bib-0035" class="usa-link" aria-describedby="jns70047-bib-0035">35</a>].</p>
<p>Misdiagnosis also contributes to diagnostic delay. In our cohort, the overall median delay in diagnosis was half a year, and there was apparent variation between CIDP variants, suggesting that the longest delays occur in focal and multifocal CIDP. Two previous single‐center studies seem to suggest longer delays occur when patients with CIDP are referred with non‐CIDP conditions from outside of specialist centers, specifically for patients with an initial non‐GBS referral [<a href="#jns70047-bib-0006" class="usa-link" aria-describedby="jns70047-bib-0006">6</a>, <a href="#jns70047-bib-0035" class="usa-link" aria-describedby="jns70047-bib-0035">35</a>]. It is likely that between countries and regions, the rates of misdiagnosis and the associated diagnostic delays will vary. While misdiagnoses can only partially explain delayed diagnoses, it is of importance to understand why, in some cases, these rates can be so high and how variant CIDP can affect this.</p>
<p>Similar proportions of patients were prescribed immunoglobulin therapy within each region; however, there were apparent variations in the proportion of patients prescribed corticosteroids. In China, 80% of patients were reported to be prescribed corticosteroids, over 40% were prescribed immune suppressants or other therapies, and a majority of patients received one or two lines of any therapy combination. The long‐term use of corticosteroids has been associated with AEs in patients with CIDP [<a href="#jns70047-bib-0036" class="usa-link" aria-describedby="jns70047-bib-0036">36</a>], and there is sparse data for the effectiveness of immune suppressants or other therapies [<a href="#jns70047-bib-0005" class="usa-link" aria-describedby="jns70047-bib-0005">5</a>].</p>
<p>Additionally, our data showed that a majority of patients in China had one or more hospitalizations in the last 12 months. A real‐world study of patients with CIDP in China noted that intravenous immunoglobulin therapy has limited availability and high cost, further suggesting that some patients may start IVIg treatment but are not able to complete a recommended course, leading to symptom relapse [<a href="#jns70047-bib-0037" class="usa-link" aria-describedby="jns70047-bib-0037">37</a>]. A randomized, double‐blind trial in the Netherlands showed that safe withdrawal from IVIg using a weaning period is possible and is suggested for clinically stable patients with CIDP [<a href="#jns70047-bib-0038" class="usa-link" aria-describedby="jns70047-bib-0038">38</a>]. Further research into the impacts of sudden treatment withdrawal could be of value in countries with less predictable access to specific treatments.</p>
<p>From our matched physician‐patient self‐reported data, disconnect was observed for overall treatment satisfaction, in which it appears that physicians more frequently indicated higher levels of satisfaction than patients, and synonymously patients more commonly reported levels of treatment dissatisfaction. This was similar in terms of symptom control, although less pronounced. Patients indicating treatment dissatisfaction may be influenced by burdens associated with the administration of treatment, having to travel to a health center, and receiving injections. These factors may have less of an impact on physician‐reported satisfaction. It is important that patients feel they can ask their physician for treatment alternatives if they are dissatisfied. A recent meta‐analysis found that independence and flexibility provided by subcutaneous immunoglobulins are preferential and that patients experienced comparable health outcomes to IVIg [<a href="#jns70047-bib-0039" class="usa-link" aria-describedby="jns70047-bib-0039">39</a>]. Treatment individualization based on patient preferences, disease behavior, and minimally effective immunoglobulin doses could be key steps to improve patient treatment satisfaction.</p>
<p>Patient reported outcome measures (PROMs) in our study indicate high levels of residual disability in the cohort overall. Patient I‐RODS scores are indicative of residual disability based on self‐reported impairment to activities of daily living. High levels of fatigue can be inferred by comparison to German FACIT norms, which were reported to be a mean (SD) of 43.5 (8.3) [<a href="#jns70047-bib-0040" class="usa-link" aria-describedby="jns70047-bib-0040">40</a>]. Levels of moderate or worse outcomes in EQ‐5D‐5L were reported for patients in each of the five domains. Based on mean EQ‐5D‐3L norms in the UK (0.856) and mean EQ‐5D‐5L norms in Germany (0.88), patients experience lower HRQoL in comparison to the general population [<a href="#jns70047-bib-0040" class="usa-link" aria-describedby="jns70047-bib-0040">40</a>, <a href="#jns70047-bib-0041" class="usa-link" aria-describedby="jns70047-bib-0041">41</a>]. While there are potential issues with the I‐RODS regarding its questions' generalizability between countries and patient understanding, validated and disease‐specific PROMs represent an important tool in the dialog between neurologists and patients, improving patient care and satisfaction [<a href="#jns70047-bib-0042" class="usa-link" aria-describedby="jns70047-bib-0042">42</a>]. Our FACIT and EQ‐5D‐5L data suggest there exists significant unmet medical need in patients with CIDP. Additionally, the presence of concomitant conditions may further add to patient burden due to associated treatment complications, an important consideration in a population that seemingly tends to have one or more comorbidities [<a href="#jns70047-bib-0034" class="usa-link" aria-describedby="jns70047-bib-0034">34</a>].</p>
<p>Patient satisfaction and PROMs point to the need for novel CIDP targeted treatments. FcRn blockers have begun to show promising results for patients with CIDP, with a recent FDA and EMA approval [<a href="#jns70047-bib-0013" class="usa-link" aria-describedby="jns70047-bib-0013">13</a>, <a href="#jns70047-bib-0014" class="usa-link" aria-describedby="jns70047-bib-0014">14</a>] and another anti‐FcRn monoclonal antibody currently being evaluated in a phase 3 clinical trial [<a href="#jns70047-bib-0043" class="usa-link" aria-describedby="jns70047-bib-0043">43</a>]. Complement pathway inhibitors also offer another possibility for the targeted treatment of patients with CIDP, with a novel inhibitor being shown to have a favorable benefit/risk profile from phase 2 clinical trial data [<a href="#jns70047-bib-0044" class="usa-link" aria-describedby="jns70047-bib-0044">44</a>] and now moving forward in two phase 3 clinical trials [<a href="#jns70047-bib-0045" class="usa-link" aria-describedby="jns70047-bib-0045">45</a>, <a href="#jns70047-bib-0046" class="usa-link" aria-describedby="jns70047-bib-0046">46</a>]. As these therapies enter clinical practice, it will be important to assess their real‐world effectiveness.</p></section><section id="jns70047-sec-0023"><h2 class="pmc_sec_title">5. Strengths and Limitations</h2>
<p>This study had a number of strengths and limitations. While minimal inclusion criteria governed the selection of the participating physicians, who were recruited to provide a geographically diverse and pragmatic sample, participation was influenced by willingness to complete the survey. The large and multinational cohort of physicians and patients included in this study aids the generalizability of the results. The cross‐sectional design of this study prevents any conclusions about causal relationships; however, the identification of significant associations was possible.</p>
<p>While physicians are asked to provide data for a consecutive series of patients to avoid selection bias, patients who visit their physician more frequently may be more severely affected than those with mild disease who do not consult their physician as frequently.</p>
<p>CIDP diagnosis was not tied to specified diagnostic criteria or additional validation, but used the presence of a physician‐confirmed diagnosis of CIDP in patient medical records, reflective of real‐world practice. This helped to provide a more holistic picture of the CIDP landscape in a multinational cohort where there may be local differences. The survey did ask physicians to report which tests and assessments were used in patient CIDP diagnosis, provided in (Supplementary Table <a href="#jns70047-supitem-0002" class="usa-link">2</a>).</p>
<p>While recall bias is a common limitation of surveys, the data for these analyses were collected at the time of each patient's appointment, which is expected to reduce this likelihood. In addition, physicians had access to patient medical records for data extraction.</p>
<p>Despite such limitations, real‐world studies play an important part in highlighting areas of concern that are not addressed in clinical trials, with the data in this study representative of current clinical practice at the time the survey was conducted.</p></section><section id="jns70047-sec-0024"><h2 class="pmc_sec_title">6. Conclusions</h2>
<p>There is evident disease burden for patients with CIDP across Europe, US, China, and Japan, despite the majority of patients being prescribed maintenance therapy, and the existence of second‐line treatment options. CIDP diagnostic delay and misdiagnoses are still common occurrences across CIDP variants. These findings may be of use to physicians in clinical practice who have CIDP patients that are not responding well to their current treatment.</p>
<section id="jns70047-sec-0025"><h3 class="pmc_sec_title">6.1. Future Study Recommendations</h3>
<p>Further studies into patient outcomes after an inadequate response to first‐line CIDP treatments are required. Additionally, as novel targeted treatments become more commonplace, it will be important to analyze patient outcomes in comparison to current practice.</p></section></section><section id="jns70047-sec-0027"><h2 class="pmc_sec_title">Disclosure</h2>
<p>Luis Querol is an employee of Hospital de la Santa Creu i Sant Pau. Luis Querol received research grants from Instituto de Salud Carlos III—Ministry of Economy and Innovation (Spain), CIBERER, Fundació La Marató, GBS‐CIDP Foundation International, and ArgenX. Luis Querol received speaker or expert testimony honoraria from CSL Behring, Novartis, Sanofi‐Genzyme, Merck, Annexon, Alnylam, ArgenX, Dianthus, LFB, Avilar Therapeutics, Lycia Therapeutics, Nuvig Therapeutics, Takeda, and Roche. Luis Querol serves at Clinical Trial Steering Committees for Sanofi Genzyme, ArgenX, and Takeda and is Principal Investigator for UCB's CIDP01 trial and Sanofi's Mobilize and Vitalize trials.</p>
<p>Simon Rinaldi is an employee of Nuffield Department of Clinical Neurosciences, University of Oxford. He is currently supported by grants from the Medical Research Council (UK), GBS|CIDP Foundation International, and British Medical Association. He has previously been supported by grants from the Medical Research Council (UK), Wellcome Trust, National Institute of Health Research (NIHR), the Pathological Society of Great Britain and Ireland, and the University of Oxford's John Fell Fund. He has received honoraria for lectures given at the request of Excemed, Fresenius, CSL Behring, UCB, argenx, the Beijing Association of Holistic and Integrated Medicine, and the Irish Institute of Clinical Neuroscience. He has been a paid consultant for argenx, Annexon, Dianthus, Takeda, and Hansa Biopharma. He is an unpaid member of the medical advisory board of the Guillain‐Barré syndrome and Related Inflammatory Neuropathies (GAIN) charity and of the Inflammatory Neuropathy Consortium (INC) board. He has previously received reduced registration fees, travel grants, and scientific prizes from the Peripheral Nerve Society. He runs a not‐for‐profit diagnostic testing service for nodal/paranodal antibodies.</p>
<p>Gerd Meyer zu Hörste is an employee of University Hospital Münster. In the last 5 years, GMzH received speaker honoraria from Alexion, LFB Pharma, Amgen, Argenx; compensation for serving on advisory boards for LFB Pharma, Immunovant, Roche; and received project‐related research funding from Merck (Germany), Biogen, Roche. He received no compensation for his activity in this study.</p>
<p>Andras Borsi, Charlotte Gary, Wim Noel, Wisam Karmous, and Giorgio Maria Boggia are employees of Johnson &amp; Johnson Innovative Medicine and may hold stock.</p>
<p>Jonathan DeCourcy, Yasmin Taylor, and Jack Wright are employees of Adelphi Real World.</p></section><section id="sec27"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="jns70047-supitem-0001"><div class="caption p"><p>
<strong>Supplementary Table 1:</strong> Symptomatology split by region/country.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12361836/bin/JNS-30-0-s003.docx" data-ga-action="click_feat_suppl" class="usa-link">JNS-30-0-s003.docx</a><sup> (62KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="jns70047-supitem-0002"><div class="caption p"><p>
<strong>Supplementary Table 2:</strong> Diagnosis and treatment split by region/country.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12361836/bin/JNS-30-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">JNS-30-0-s001.docx</a><sup> (66.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="jns70047-supitem-0003"><div class="caption p"><p>
<strong>Supplementary Table 3:</strong> Physician reported overall satisfaction with, and perceived level of symptom control on, current drug treatment, and split by region/country.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12361836/bin/JNS-30-0-s004.docx" data-ga-action="click_feat_suppl" class="usa-link">JNS-30-0-s004.docx</a><sup> (61.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="jns70047-supitem-0004"><div class="caption p"><p>
<strong>Supplementary Table 4:</strong> Healthcare resource utilization split by region/country.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12361836/bin/JNS-30-0-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">JNS-30-0-s002.docx</a><sup> (76.3KB, docx) </sup>
</div></div></section></section><section id="jns70047-sec-0026" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>Medical writing and editorial support on behalf of Adelphi Real World (Bollington, United Kingdom) was respectively provided by Simon Pimm and Gary Sidgwick, under the guidance of the authors and in accordance with Good Publication Practice 2022 (GPP 2022) guidelines (<a href="https://www.ismpp.org/gpp-2022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ismpp.org/gpp‐2022</a>).</p></section><section id="notes1"><p>

Querol L., Rinaldi S., Borsi A., et al., “Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape,” Journal of the Peripheral Nervous System
30, no. 3 (2025): e70047, 10.1111/jns.70047.
</p>
<section id="jns70047-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="jns70047-note-0001"><p>
<strong>Funding:</strong> The authors received no specific funding for this work.</p></div></div></section></section><section id="jns70047-sec-0029"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section><section id="jns70047-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="jns70047-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="jns70047-bib-0001">
<span class="label">1.</span><cite>
Mathey E. K., Park S. B., Hughes R. A., et al., “Chronic Inflammatory Demyelinating Polyradiculoneuropathy: From Pathology to Phenotype,” Journal of Neurology, Neurosurgery, and Psychiatry
86, no. 9 (2015): 973–985, 10.1136/jnnp-2014-309697.
</cite> [<a href="https://doi.org/10.1136/jnnp-2014-309697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4552934/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25677463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology,%20Neurosurgery,%20and%20Psychiatry&amp;title=Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy:%20From%20Pathology%20to%20Phenotype&amp;author=E.%20K.%20Mathey&amp;author=S.%20B.%20Park&amp;author=R.%20A.%20Hughes&amp;volume=86&amp;issue=9&amp;publication_year=2015&amp;pages=973-985&amp;pmid=25677463&amp;doi=10.1136/jnnp-2014-309697&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0002">
<span class="label">2.</span><cite>
Dziadkowiak E., Waliszewska‐Prosol M., Nowakowska‐Kotas M., Budrewicz S., Koszewicz Z., and Koszewicz M., “Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP),” International Journal of Molecular Sciences
23, no. 1 (2021): 179, 10.3390/ijms23010179.
</cite> [<a href="https://doi.org/10.3390/ijms23010179" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8745770/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35008604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Pathophysiology%20of%20the%20Different%20Clinical%20Phenotypes%20of%20Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy%20(CIDP)&amp;author=E.%20Dziadkowiak&amp;author=M.%20Waliszewska%E2%80%90Prosol&amp;author=M.%20Nowakowska%E2%80%90Kotas&amp;author=S.%20Budrewicz&amp;author=Z.%20Koszewicz&amp;volume=23&amp;issue=1&amp;publication_year=2021&amp;pages=179&amp;pmid=35008604&amp;doi=10.3390/ijms23010179&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0003">
<span class="label">3.</span><cite>
Koike H. and Katsuno M., “Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights Into Classification and Therapeutic Strategy,” Neurology and Therapy
9, no. 2 (2020): 213–227, 10.1007/s40120-020-00190-8.
</cite> [<a href="https://doi.org/10.1007/s40120-020-00190-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7606443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32410146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology%20and%20Therapy&amp;title=Pathophysiology%20of%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy:%20Insights%20Into%20Classification%20and%20Therapeutic%20Strategy&amp;author=H.%20Koike&amp;author=M.%20Katsuno&amp;volume=9&amp;issue=2&amp;publication_year=2020&amp;pages=213-227&amp;pmid=32410146&amp;doi=10.1007/s40120-020-00190-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0004">
<span class="label">4.</span><cite>
Querol L., Crabtree M., Herepath M., et al., “Systematic Literature Review of Burden of Illness in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),” Journal of Neurology
268, no. 10 (2021): 3706–3716, 10.1007/s00415-020-09998-8.
</cite> [<a href="https://doi.org/10.1007/s00415-020-09998-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8463372/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32583051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology&amp;title=Systematic%20Literature%20Review%20of%20Burden%20of%20Illness%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy%20(CIDP)&amp;author=L.%20Querol&amp;author=M.%20Crabtree&amp;author=M.%20Herepath&amp;volume=268&amp;issue=10&amp;publication_year=2021&amp;pages=3706-3716&amp;pmid=32583051&amp;doi=10.1007/s00415-020-09998-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0005">
<span class="label">5.</span><cite>
Van den Bergh P. Y. K., van Doorn P. A., Hadden R. D. M., et al., “European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force‐Second Revision,” European Journal of Neurology
28, no. 11 (2021): 3556–3583, 10.1111/ene.14959.
</cite> [<a href="https://doi.org/10.1111/ene.14959" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34327760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Neurology&amp;title=European%20Academy%20of%20Neurology/Peripheral%20Nerve%20Society%20Guideline%20on%20Diagnosis%20and%20Treatment%20of%20Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy:%20Report%20of%20a%20Joint%20Task%20Force%E2%80%90Second%20Revision&amp;author=P.%20Y.%20K.%20Van%20den%20Bergh&amp;author=P.%20A.%20van%20Doorn&amp;author=R.%20D.%20M.%20Hadden&amp;volume=28&amp;issue=11&amp;publication_year=2021&amp;pages=3556-3583&amp;pmid=34327760&amp;doi=10.1111/ene.14959&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0006">
<span class="label">6.</span><cite>
Broers M. C., Bunschoten C., Drenthen J., et al., “Misdiagnosis and Diagnostic Pitfalls of Chronic Inflammatory Demyelinating Polyradiculoneuropathy,” European Journal of Neurology
28, no. 6 (2021): 2065–2073, 10.1111/ene.14796.
</cite> [<a href="https://doi.org/10.1111/ene.14796" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8252611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33657260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Neurology&amp;title=Misdiagnosis%20and%20Diagnostic%20Pitfalls%20of%20Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy&amp;author=M.%20C.%20Broers&amp;author=C.%20Bunschoten&amp;author=J.%20Drenthen&amp;volume=28&amp;issue=6&amp;publication_year=2021&amp;pages=2065-2073&amp;pmid=33657260&amp;doi=10.1111/ene.14796&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0007">
<span class="label">7.</span><cite>
Gelinas D., Katz J., Nisbet P., and England J. D., “Current Practice Patterns in CIDP: A Cross‐Sectional Survey of Neurologists in the United States,” Journal of the Neurological Sciences
397 (2019): 84–91, 10.1016/j.jns.2018.11.031.
</cite> [<a href="https://doi.org/10.1016/j.jns.2018.11.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30597419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Neurological%20Sciences&amp;title=Current%20Practice%20Patterns%20in%20CIDP:%20A%20Cross%E2%80%90Sectional%20Survey%20of%20Neurologists%20in%20the%20United%20States&amp;author=D.%20Gelinas&amp;author=J.%20Katz&amp;author=P.%20Nisbet&amp;author=J.%20D.%20England&amp;volume=397&amp;publication_year=2019&amp;pages=84-91&amp;pmid=30597419&amp;doi=10.1016/j.jns.2018.11.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0008">
<span class="label">8.</span><cite>
Allen J. A., “The Misdiagnosis of CIDP: A Review,” Neurology and Therapy
9, no. 1 (2020): 43–54, 10.1007/s40120-020-00184-6.
</cite> [<a href="https://doi.org/10.1007/s40120-020-00184-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7229131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32219701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology%20and%20Therapy&amp;title=The%20Misdiagnosis%20of%20CIDP:%20A%20Review&amp;author=J.%20A.%20Allen&amp;volume=9&amp;issue=1&amp;publication_year=2020&amp;pages=43-54&amp;pmid=32219701&amp;doi=10.1007/s40120-020-00184-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0009">
<span class="label">9.</span><cite>
Allen J. A. and Lewis R. A., “CIDP Diagnostic Pitfalls and Perception of Treatment Benefit,” Neurology
85, no. 6 (2015): 498–504, 10.1212/wnl.0000000000001833.
</cite> [<a href="https://doi.org/10.1212/wnl.0000000000001833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26180143/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=CIDP%20Diagnostic%20Pitfalls%20and%20Perception%20of%20Treatment%20Benefit&amp;author=J.%20A.%20Allen&amp;author=R.%20A.%20Lewis&amp;volume=85&amp;issue=6&amp;publication_year=2015&amp;pages=498-504&amp;pmid=26180143&amp;doi=10.1212/wnl.0000000000001833&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0010">
<span class="label">10.</span><cite>
Bus S. R., de Haan R. J., Vermeulen M., van Schaik I. N., and Eftimov F., “Intravenous Immunoglobulin for Chronic Inflammatory Demyelinating Polyradiculoneuropathy,” Cochrane Database of Systematic Reviews
2, no. 2 (2024): Cd001797, 10.1002/14651858.CD001797.pub4.
</cite> [<a href="https://doi.org/10.1002/14651858.CD001797.pub4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10865446/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38353301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20of%20Systematic%20Reviews&amp;title=Intravenous%20Immunoglobulin%20for%20Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy&amp;author=S.%20R.%20Bus&amp;author=R.%20J.%20de%20Haan&amp;author=M.%20Vermeulen&amp;author=I.%20N.%20van%20Schaik&amp;author=F.%20Eftimov&amp;volume=2&amp;issue=2&amp;publication_year=2024&amp;pages=Cd001797&amp;pmid=38353301&amp;doi=10.1002/14651858.CD001797.pub4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0011">
<span class="label">11.</span><cite>
Fehmi J., Bellanti R., Misbah S. A., Bhattacharjee A., and Rinaldi S., “Treatment of CIDP,” Practical Neurology
23, no. 1 (2023): 46–53, 10.1136/pn-2021-002991.
</cite> [<a href="https://doi.org/10.1136/pn-2021-002991" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36109154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Practical%20Neurology&amp;title=Treatment%20of%20CIDP&amp;author=J.%20Fehmi&amp;author=R.%20Bellanti&amp;author=S.%20A.%20Misbah&amp;author=A.%20Bhattacharjee&amp;author=S.%20Rinaldi&amp;volume=23&amp;issue=1&amp;publication_year=2023&amp;pages=46-53&amp;pmid=36109154&amp;doi=10.1136/pn-2021-002991&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0012">
<span class="label">12.</span><cite>
Mair D., Madi H., Eftimov F., Lunn M. P., and Keddie S., “Novel Therapies in CIDP,” Journal of Neurology, Neurosurgery, and Psychiatry
96 (2024): 38–46, 10.1136/jnnp-2024-334165.
</cite> [<a href="https://doi.org/10.1136/jnnp-2024-334165" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39358011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology,%20Neurosurgery,%20and%20Psychiatry&amp;title=Novel%20Therapies%20in%20CIDP&amp;author=D.%20Mair&amp;author=H.%20Madi&amp;author=F.%20Eftimov&amp;author=M.%20P.%20Lunn&amp;author=S.%20Keddie&amp;volume=96&amp;publication_year=2024&amp;pages=38-46&amp;pmid=39358011&amp;doi=10.1136/jnnp-2024-334165&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0013">
<span class="label">13.</span><cite>
European Medicines Agency
, “Vyvgart – opinion on variation to marketing authorisation,” 2025, <a href="https://www.ema.europa.eu/en/medicines/human/variation/vyvgart" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ema.europa.eu/en/medicines/human/variation/vyvgart</a>.</cite>
</li>
<li id="jns70047-bib-0014">
<span class="label">14.</span><cite>
U.S. Food &amp; Drug Administration
, “FDA approves treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults,” 2025, <a href="https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-chronic-inflammatory-demyelinating-polyneuropathy-cidp-adults" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/drugs/news‐events‐human‐drugs/fda‐approves‐treatment‐chronic‐inflammatory‐demyelinating‐polyneuropathy‐cidp‐adults</a>.</cite>
</li>
<li id="jns70047-bib-0015">
<span class="label">15.</span><cite>
Al‐Zuhairy A. and Jakobsen J., “Outcome in Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review and Meta‐Analysis,” Muscle &amp; Nerve
68, no. 4 (2023): 388–396, 10.1002/mus.27820.
</cite> [<a href="https://doi.org/10.1002/mus.27820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36928889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Muscle%20&amp;%20Nerve&amp;title=Outcome%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=A.%20Al%E2%80%90Zuhairy&amp;author=J.%20Jakobsen&amp;volume=68&amp;issue=4&amp;publication_year=2023&amp;pages=388-396&amp;pmid=36928889&amp;doi=10.1002/mus.27820&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0016">
<span class="label">16.</span><cite>
Bus S. R. M., Broers M. C., Lucke I. M., et al., “Clinical Outcome of CIDP One Year After Start of Treatment: A Prospective Cohort Study,” Journal of Neurology
269, no. 2 (2022): 945–955, 10.1007/s00415-021-10677-5.
</cite> [<a href="https://doi.org/10.1007/s00415-021-10677-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8782785/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34173873/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology&amp;title=Clinical%20Outcome%20of%20CIDP%20One%20Year%20After%20Start%20of%20Treatment:%20A%20Prospective%20Cohort%20Study&amp;author=S.%20R.%20M.%20Bus&amp;author=M.%20C.%20Broers&amp;author=I.%20M.%20Lucke&amp;volume=269&amp;issue=2&amp;publication_year=2022&amp;pages=945-955&amp;pmid=34173873&amp;doi=10.1007/s00415-021-10677-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0017">
<span class="label">17.</span><cite>
Rajabally Y. A., Min Y. G., Nazeer K. K., and Englezou C., “Treatment Response Amplitude and Timing in Chronic Inflammatory Demyelinating Polyneuropathy With Routine Care: Study of a UK Cohort,” European Journal of Neurology
31, no. 10 (2024): e16399, 10.1111/ene.16399.
</cite> [<a href="https://doi.org/10.1111/ene.16399" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11414796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38980202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Neurology&amp;title=Treatment%20Response%20Amplitude%20and%20Timing%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy%20With%20Routine%20Care:%20Study%20of%20a%20UK%20Cohort&amp;author=Y.%20A.%20Rajabally&amp;author=Y.%20G.%20Min&amp;author=K.%20K.%20Nazeer&amp;author=C.%20Englezou&amp;volume=31&amp;issue=10&amp;publication_year=2024&amp;pages=e16399&amp;pmid=38980202&amp;doi=10.1111/ene.16399&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0018">
<span class="label">18.</span><cite>
Anderson P., Benford M., Harris N., Karavali M., and Piercy J., “Real‐World Physician and Patient Behaviour Across Countries: Disease‐Specific Programmes ‐ a Means to Understand,” Current Medical Research and Opinion
24, no. 11 (2008): 3063–3072, 10.1185/03007990802457040.
</cite> [<a href="https://doi.org/10.1185/03007990802457040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18826746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Medical%20Research%20and%20Opinion&amp;title=Real%E2%80%90World%20Physician%20and%20Patient%20Behaviour%20Across%20Countries:%20Disease%E2%80%90Specific%20Programmes%20%E2%80%90%20a%20Means%20to%20Understand&amp;author=P.%20Anderson&amp;author=M.%20Benford&amp;author=N.%20Harris&amp;author=M.%20Karavali&amp;author=J.%20Piercy&amp;volume=24&amp;issue=11&amp;publication_year=2008&amp;pages=3063-3072&amp;pmid=18826746&amp;doi=10.1185/03007990802457040&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0019">
<span class="label">19.</span><cite>
Babineaux S. M., Curtis B., Holbrook T., Milligan G., and Piercy J., “Evidence for Validity of a National Physician and Patient‐Reported, Cross‐Sectional Survey in China and UK: The Disease Specific Programme,” BMJ Open
6, no. 8 (2016): e010352, 10.1136/bmjopen-2015-010352.</cite> [<a href="https://doi.org/10.1136/bmjopen-2015-010352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5013497/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27531722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&amp;title=Evidence%20for%20Validity%20of%20a%20National%20Physician%20and%20Patient%E2%80%90Reported,%20Cross%E2%80%90Sectional%20Survey%20in%20China%20and%20UK:%20The%20Disease%20Specific%20Programme&amp;author=S.%20M.%20Babineaux&amp;author=B.%20Curtis&amp;author=T.%20Holbrook&amp;author=G.%20Milligan&amp;author=J.%20Piercy&amp;volume=6&amp;issue=8&amp;publication_year=2016&amp;pages=e010352&amp;pmid=27531722&amp;doi=10.1136/bmjopen-2015-010352&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0020">
<span class="label">20.</span><cite>
Higgins V., Piercy J., Roughley A., et al., “Trends in Medication Use in Patients With Type 2 Diabetes Mellitus: A Long‐Term View of Real‐World Treatment Between 2000 and 2015,” Diabetes, Metabolic Syndrome and Obesity
9 (2016): 371–380, 10.2147/DMSO.S120101.</cite> [<a href="https://doi.org/10.2147/DMSO.S120101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5098530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27843332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Metabolic%20Syndrome%20and%20Obesity&amp;title=Trends%20in%20Medication%20Use%20in%20Patients%20With%20Type%202%20Diabetes%20Mellitus:%20A%20Long%E2%80%90Term%20View%20of%20Real%E2%80%90World%20Treatment%20Between%202000%20and%202015&amp;author=V.%20Higgins&amp;author=J.%20Piercy&amp;author=A.%20Roughley&amp;volume=9&amp;publication_year=2016&amp;pages=371-380&amp;pmid=27843332&amp;doi=10.2147/DMSO.S120101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0021">
<span class="label">21.</span><cite>
Anderson P., Higgins V., Courcy J., et al., “Real‐World Evidence Generation From Patients, Their Caregivers and Physicians Supporting Clinical, Regulatory and Guideline Decisions: An Update on Disease Specific Programmes,” Current Medical Research and Opinion
39, no. 12 (2023): 1707–1715, 10.1080/03007995.2023.2279679.
</cite> [<a href="https://doi.org/10.1080/03007995.2023.2279679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37933204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Medical%20Research%20and%20Opinion&amp;title=Real%E2%80%90World%20Evidence%20Generation%20From%20Patients,%20Their%20Caregivers%20and%20Physicians%20Supporting%20Clinical,%20Regulatory%20and%20Guideline%20Decisions:%20An%20Update%20on%20Disease%20Specific%20Programmes&amp;author=P.%20Anderson&amp;author=V.%20Higgins&amp;author=J.%20Courcy&amp;volume=39&amp;issue=12&amp;publication_year=2023&amp;pages=1707-1715&amp;pmid=37933204&amp;doi=10.1080/03007995.2023.2279679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0022">
<span class="label">22.</span><cite>
Hughes R., Bensa S., Willison H., et al., “Randomized Controlled Trial of Intravenous Immunoglobulin Versus Oral Prednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy,” Annals of Neurology
50, no. 2 (2001): 195–201, 10.1002/ana.1088.
</cite> [<a href="https://doi.org/10.1002/ana.1088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11506402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Neurology&amp;title=Randomized%20Controlled%20Trial%20of%20Intravenous%20Immunoglobulin%20Versus%20Oral%20Prednisolone%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy&amp;author=R.%20Hughes&amp;author=S.%20Bensa&amp;author=H.%20Willison&amp;volume=50&amp;issue=2&amp;publication_year=2001&amp;pages=195-201&amp;pmid=11506402&amp;doi=10.1002/ana.1088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0023">
<span class="label">23.</span><cite>
van Nes S. I., Vanhoutte E. K., van Doorn P. A., et al., “Rasch‐Built Overall Disability Scale (R‐ODS) for Immune‐Mediated Peripheral Neuropathies,” Neurology
76, no. 4 (2011): 337–345, 10.1212/WNL.0b013e318208824b.
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e318208824b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21263135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Rasch%E2%80%90Built%20Overall%20Disability%20Scale%20(R%E2%80%90ODS)%20for%20Immune%E2%80%90Mediated%20Peripheral%20Neuropathies&amp;author=S.%20I.%20van%20Nes&amp;author=E.%20K.%20Vanhoutte&amp;author=P.%20A.%20van%20Doorn&amp;volume=76&amp;issue=4&amp;publication_year=2011&amp;pages=337-345&amp;pmid=21263135&amp;doi=10.1212/WNL.0b013e318208824b&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0024">
<span class="label">24.</span><cite>
Webster K., Cella D., and Yost K., “The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, Applications, and Interpretation,” Health and Quality of Life Outcomes
1 (2003): 79, 10.1186/1477-7525-1-79.
</cite> [<a href="https://doi.org/10.1186/1477-7525-1-79" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC317391/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14678568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Health%20and%20Quality%20of%20Life%20Outcomes&amp;title=The%20Functional%20Assessment%20of%20Chronic%20Illness%20Therapy%20(FACIT)%20Measurement%20System:%20Properties,%20Applications,%20and%20Interpretation&amp;author=K.%20Webster&amp;author=D.%20Cella&amp;author=K.%20Yost&amp;volume=1&amp;publication_year=2003&amp;pages=79&amp;pmid=14678568&amp;doi=10.1186/1477-7525-1-79&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0025">
<span class="label">25.</span><cite>
Cella D., de la Loge C., Fofana F., et al., “The Functional Assessment of Chronic Illness Therapy‐Fatigue (FACIT‐Fatigue) Scale in Patients With Axial Spondyloarthritis: Psychometric Properties and Clinically Meaningful Thresholds for Interpretation,” Journal of Patient Report Outcomes
8, no. 1 (2024): 92, 10.1186/s41687-024-00769-x.</cite> [<a href="https://doi.org/10.1186/s41687-024-00769-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11319684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39133438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Patient%20Report%20Outcomes&amp;title=The%20Functional%20Assessment%20of%20Chronic%20Illness%20Therapy%E2%80%90Fatigue%20(FACIT%E2%80%90Fatigue)%20Scale%20in%20Patients%20With%20Axial%20Spondyloarthritis:%20Psychometric%20Properties%20and%20Clinically%20Meaningful%20Thresholds%20for%20Interpretation&amp;author=D.%20Cella&amp;author=C.%20de%20la%20Loge&amp;author=F.%20Fofana&amp;volume=8&amp;issue=1&amp;publication_year=2024&amp;pages=92&amp;pmid=39133438&amp;doi=10.1186/s41687-024-00769-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0026">
<span class="label">26.</span><cite>
Janssen M. F., Pickard A. S., Golicki D., et al., “Measurement Properties of the EQ‐5D‐5L Compared to the EQ‐5D‐3L Across Eight Patient Groups: A Multi‐Country Study,” Quality of Life Research
22, no. 7 (2013): 1717–1727, 10.1007/s11136-012-0322-4.
</cite> [<a href="https://doi.org/10.1007/s11136-012-0322-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3764313/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23184421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Quality%20of%20Life%20Research&amp;title=Measurement%20Properties%20of%20the%20EQ%E2%80%905D%E2%80%905L%20Compared%20to%20the%20EQ%E2%80%905D%E2%80%903L%20Across%20Eight%20Patient%20Groups:%20A%20Multi%E2%80%90Country%20Study&amp;author=M.%20F.%20Janssen&amp;author=A.%20S.%20Pickard&amp;author=D.%20Golicki&amp;volume=22&amp;issue=7&amp;publication_year=2013&amp;pages=1717-1727&amp;pmid=23184421&amp;doi=10.1007/s11136-012-0322-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0027">
<span class="label">27.</span><cite>
Herdman M., Gudex C., Lloyd A., et al., “Development and Preliminary Testing of the New Five‐Level Version of EQ‐5D (EQ‐5D‐5L),” Quality of Life Research
20, no. 10 (2011): 1727–1736, 10.1007/s11136-011-9903-x.
</cite> [<a href="https://doi.org/10.1007/s11136-011-9903-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3220807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21479777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Quality%20of%20Life%20Research&amp;title=Development%20and%20Preliminary%20Testing%20of%20the%20New%20Five%E2%80%90Level%20Version%20of%20EQ%E2%80%905D%20(EQ%E2%80%905D%E2%80%905L)&amp;author=M.%20Herdman&amp;author=C.%20Gudex&amp;author=A.%20Lloyd&amp;volume=20&amp;issue=10&amp;publication_year=2011&amp;pages=1727-1736&amp;pmid=21479777&amp;doi=10.1007/s11136-011-9903-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0028">
<span class="label">28.</span><cite>
NICE
, “Position statement on use of the EQ‐5D‐5L value set for England (updated October 2019),” 2024, <a href="https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.nice.org.uk/about/what‐we‐do/our‐programmes/nice‐guidance/technology‐appraisal‐guidance/eq‐5d‐5l</a>.</cite>
</li>
<li id="jns70047-bib-0029">
<span class="label">29.</span><cite>
Hernandez‐Alava M. and Pudney S., “Econometric Modelling of Multiple Self‐Reports of Health States: The Switch From EQ‐5D‐3L to EQ‐5D‐5L in Evaluating Drug Therapies for Rheumatoid Arthritis,” Journal of Health Economics
55 (2017): 139–152, 10.1016/j.jhealeco.2017.06.013.
</cite> [<a href="https://doi.org/10.1016/j.jhealeco.2017.06.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5597047/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28778350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Health%20Economics&amp;title=Econometric%20Modelling%20of%20Multiple%20Self%E2%80%90Reports%20of%20Health%20States:%20The%20Switch%20From%20EQ%E2%80%905D%E2%80%903L%20to%20EQ%E2%80%905D%E2%80%905L%20in%20Evaluating%20Drug%20Therapies%20for%20Rheumatoid%20Arthritis&amp;author=M.%20Hernandez%E2%80%90Alava&amp;author=S.%20Pudney&amp;volume=55&amp;publication_year=2017&amp;pages=139-152&amp;pmid=28778350&amp;doi=10.1016/j.jhealeco.2017.06.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0030">
<span class="label">30.</span><cite>
Hernandez Alava M., Pudney S., and Wailoo A., “The EQ‐5D‐5L Value Set for England: Findings of a Quality Assurance Program,” Value in Health
23, no. 5 (2020): 642–648, 10.1016/j.jval.2019.10.017.
</cite> [<a href="https://doi.org/10.1016/j.jval.2019.10.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32389230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Value%20in%20Health&amp;title=The%20EQ%E2%80%905D%E2%80%905L%20Value%20Set%20for%20England:%20Findings%20of%20a%20Quality%20Assurance%20Program&amp;author=M.%20Hernandez%20Alava&amp;author=S.%20Pudney&amp;author=A.%20Wailoo&amp;volume=23&amp;issue=5&amp;publication_year=2020&amp;pages=642-648&amp;pmid=32389230&amp;doi=10.1016/j.jval.2019.10.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0031">
<span class="label">31.</span><cite>
European Pharmaceutical Market Research Association (EphMRA)
, “Code of Conduct,” 2022, <a href="https://www.ephmra.org/code-conduct-aer" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ephmra.org/code‐conduct‐aer</a>.</cite>
</li>
<li id="jns70047-bib-0032">
<span class="label">32.</span><cite>
US Department of Health and Human Services
, “Summary of the HIPAA Privacy Rule,” 2022, <a href="http://www.hhs.gov/sites/default/files/privacysummary.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.hhs.gov/sites/default/files/privacysummary.pdf</a>.</cite>
</li>
<li id="jns70047-bib-0033">
<span class="label">33.</span><cite>
Health Information Technology (HITECH)
, “Health Information Technology Act. US Department of Health and Human Services,” 2022, <a href="https://www.healthit.gov/sites/default/files/hitech_act_excerpt_from_arra_with_index.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.healthit.gov/sites/default/files/hitech_act_excerpt_from_arra_with_index.pdf</a>.</cite>
</li>
<li id="jns70047-bib-0034">
<span class="label">34.</span><cite>
Doneddu P. E., Cocito D., Manganelli F., et al., “Frequency of Diabetes and Other Comorbidities in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Their Impact on Clinical Presentation and Response to Therapy,” Journal of Neurology, Neurosurgery, and Psychiatry
91, no. 10 (2020): 1092–1099, 10.1136/jnnp-2020-323615.
</cite> [<a href="https://doi.org/10.1136/jnnp-2020-323615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32868387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology,%20Neurosurgery,%20and%20Psychiatry&amp;title=Frequency%20of%20Diabetes%20and%20Other%20Comorbidities%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy%20and%20Their%20Impact%20on%20Clinical%20Presentation%20and%20Response%20to%20Therapy&amp;author=P.%20E.%20Doneddu&amp;author=D.%20Cocito&amp;author=F.%20Manganelli&amp;volume=91&amp;issue=10&amp;publication_year=2020&amp;pages=1092-1099&amp;pmid=32868387&amp;doi=10.1136/jnnp-2020-323615&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0035">
<span class="label">35.</span><cite>
Chaudhary U. J. and Rajabally Y. A., “Underdiagnosis and Diagnostic Delay in Chronic Inflammatory Demyelinating Polyneuropathy,” Journal of Neurology
268, no. 4 (2021): 1366–1373, 10.1007/s00415-020-10287-7.
</cite> [<a href="https://doi.org/10.1007/s00415-020-10287-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7990867/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33170339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology&amp;title=Underdiagnosis%20and%20Diagnostic%20Delay%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy&amp;author=U.%20J.%20Chaudhary&amp;author=Y.%20A.%20Rajabally&amp;volume=268&amp;issue=4&amp;publication_year=2021&amp;pages=1366-1373&amp;pmid=33170339&amp;doi=10.1007/s00415-020-10287-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0036">
<span class="label">36.</span><cite>
Oaklander A. L., Lunn M. P., Hughes R. A., van Schaik I. N., Frost C., and Chalk C. H., “Treatments for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): An Overview of Systematic Reviews,” Cochrane Database of Systematic Reviews
1, no. 1 (2017): CD010369, 10.1002/14651858.CD010369.pub2.
</cite> [<a href="https://doi.org/10.1002/14651858.CD010369.pub2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5468847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28084646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20of%20Systematic%20Reviews&amp;title=Treatments%20for%20Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy%20(CIDP):%20An%20Overview%20of%20Systematic%20Reviews&amp;author=A.%20L.%20Oaklander&amp;author=M.%20P.%20Lunn&amp;author=R.%20A.%20Hughes&amp;author=I.%20N.%20van%20Schaik&amp;author=C.%20Frost&amp;volume=1&amp;issue=1&amp;publication_year=2017&amp;pages=CD010369&amp;pmid=28084646&amp;doi=10.1002/14651858.CD010369.pub2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0037">
<span class="label">37.</span><cite>
Zheng Y., Hu J., Sun C., et al., “Insights Into Refractory Chronic Inflammatory Demyelinating Polyneuropathy: A Comprehensive Real‐World Study,” Frontiers in Neurology
15 (2024): 1326874, 10.3389/fneur.2024.1326874.
</cite> [<a href="https://doi.org/10.3389/fneur.2024.1326874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10865491/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38356878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Neurology&amp;title=Insights%20Into%20Refractory%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy:%20A%20Comprehensive%20Real%E2%80%90World%20Study&amp;author=Y.%20Zheng&amp;author=J.%20Hu&amp;author=C.%20Sun&amp;volume=15&amp;publication_year=2024&amp;pages=1326874&amp;pmid=38356878&amp;doi=10.3389/fneur.2024.1326874&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0038">
<span class="label">38.</span><cite>
Adrichem M. E., Lucke I. M., Vrancken A., et al., “Withdrawal of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy,” Brain
145, no. 5 (2022): 1641–1652, 10.1093/brain/awac054.
</cite> [<a href="https://doi.org/10.1093/brain/awac054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9166547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35139161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Withdrawal%20of%20Intravenous%20Immunoglobulin%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyradiculoneuropathy&amp;author=M.%20E.%20Adrichem&amp;author=I.%20M.%20Lucke&amp;author=A.%20Vrancken&amp;volume=145&amp;issue=5&amp;publication_year=2022&amp;pages=1641-1652&amp;pmid=35139161&amp;doi=10.1093/brain/awac054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0039">
<span class="label">39.</span><cite>
Ramzi A., Maya S., Balousha N., et al., “Subcutaneous Immunoglobulins (SCIG) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Comprehensive Systematic Review of Clinical Studies and Meta‐Analysis,” Neurological Sciences
45, no. 11 (2024): 5213–5230, 10.1007/s10072-024-07640-3.
</cite> [<a href="https://doi.org/10.1007/s10072-024-07640-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11470904/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38937399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurological%20Sciences&amp;title=Subcutaneous%20Immunoglobulins%20(SCIG)%20for%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy%20(CIDP):%20A%20Comprehensive%20Systematic%20Review%20of%20Clinical%20Studies%20and%20Meta%E2%80%90Analysis&amp;author=A.%20Ramzi&amp;author=S.%20Maya&amp;author=N.%20Balousha&amp;volume=45&amp;issue=11&amp;publication_year=2024&amp;pages=5213-5230&amp;pmid=38937399&amp;doi=10.1007/s10072-024-07640-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0040">
<span class="label">40.</span><cite>
Montan I., Lowe B., Cella D., Mehnert A., and Hinz A., “General Population Norms for the Functional Assessment of Chronic Illness Therapy (FACIT)‐fatigue Scale,” Value in Health
21, no. 11 (2018): 1313–1321, 10.1016/j.jval.2018.03.013.
</cite> [<a href="https://doi.org/10.1016/j.jval.2018.03.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30442279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Value%20in%20Health&amp;title=General%20Population%20Norms%20for%20the%20Functional%20Assessment%20of%20Chronic%20Illness%20Therapy%20(FACIT)%E2%80%90fatigue%20Scale&amp;author=I.%20Montan&amp;author=B.%20Lowe&amp;author=D.%20Cella&amp;author=A.%20Mehnert&amp;author=A.%20Hinz&amp;volume=21&amp;issue=11&amp;publication_year=2018&amp;pages=1313-1321&amp;pmid=30442279&amp;doi=10.1016/j.jval.2018.03.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0041">
<span class="label">41.</span><cite>
Janssen M. F., Szende A., Cabases J., Ramos‐Goni J. M., Vilagut G., and Konig H. H., “Population Norms for the EQ‐5D‐3L: A Cross‐Country Analysis of Population Surveys for 20 Countries,” European Journal of Health Economics
20, no. 2 (2019): 205–216, 10.1007/s10198-018-0955-5.</cite> [<a href="https://doi.org/10.1007/s10198-018-0955-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6438939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29445941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Health%20Economics&amp;title=Population%20Norms%20for%20the%20EQ%E2%80%905D%E2%80%903L:%20A%20Cross%E2%80%90Country%20Analysis%20of%20Population%20Surveys%20for%2020%20Countries&amp;author=M.%20F.%20Janssen&amp;author=A.%20Szende&amp;author=J.%20Cabases&amp;author=J.%20M.%20Ramos%E2%80%90Goni&amp;author=G.%20Vilagut&amp;volume=20&amp;issue=2&amp;publication_year=2019&amp;pages=205-216&amp;pmid=29445941&amp;doi=10.1007/s10198-018-0955-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0042">
<span class="label">42.</span><cite>
White D., Englezou C., and Rajabally Y. A., “Patient Perceptions of Outcome Measures in Chronic Inflammatory Demyelinating Polyneuropathy: A Study of the Inflammatory Rasch‐Built Overall Disability Scale,” European Journal of Neurology
28, no. 8 (2021): 2596–2602, 10.1111/ene.14907.
</cite> [<a href="https://doi.org/10.1111/ene.14907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33969583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Neurology&amp;title=Patient%20Perceptions%20of%20Outcome%20Measures%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy:%20A%20Study%20of%20the%20Inflammatory%20Rasch%E2%80%90Built%20Overall%20Disability%20Scale&amp;author=D.%20White&amp;author=C.%20Englezou&amp;author=Y.%20A.%20Rajabally&amp;volume=28&amp;issue=8&amp;publication_year=2021&amp;pages=2596-2602&amp;pmid=33969583&amp;doi=10.1111/ene.14907&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0043">
<span class="label">43.</span><cite>
Janssen Research &amp; Development
, “Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),” 2025, <a href="https://clinicaltrials.gov/study/NCT05327114" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/study/NCT05327114</a>.</cite>
</li>
<li id="jns70047-bib-0044">
<span class="label">44.</span><cite>
Querol L., Lewis R., Hartung H.‐P., et al., “Preliminary Efficacy and Safety Data From the Phase 2 Trial of Riliprubart (SAR445088), a Humanized Monoclonal Antibody Targeting Complement C1s, in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (S15.008),” Neurology
102 (2024): 2552, 10.1212/wnl.0000000000204596.</cite> [<a href="https://doi.org/10.1212/wnl.0000000000204596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Preliminary%20Efficacy%20and%20Safety%20Data%20From%20the%20Phase%202%20Trial%20of%20Riliprubart%20(SAR445088),%20a%20Humanized%20Monoclonal%20Antibody%20Targeting%20Complement%20C1s,%20in%20Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy%20(CIDP)%20(S15.008)&amp;author=L.%20Querol&amp;author=R.%20Lewis&amp;author=H.%E2%80%90P.%20Hartung&amp;volume=102&amp;publication_year=2024&amp;pages=2552&amp;doi=10.1212/wnl.0000000000204596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jns70047-bib-0045">
<span class="label">45.</span><cite>
Sanofi
, “A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (VITALIZE),” 2025, <a href="https://clinicaltrials.gov/study/NCT06290141" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/study/NCT06290141</a>.</cite>
</li>
<li id="jns70047-bib-0046">
<span class="label">46.</span><cite>
Sanofi
, “A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work (MOBILIZE),” 2025, <a href="https://clinicaltrials.gov/study/NCT06290128" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/study/NCT06290128</a>.</cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Supplementary Table 1:</strong> Symptomatology split by region/country.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12361836/bin/JNS-30-0-s003.docx" data-ga-action="click_feat_suppl" class="usa-link">JNS-30-0-s003.docx</a><sup> (62KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>
<strong>Supplementary Table 2:</strong> Diagnosis and treatment split by region/country.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12361836/bin/JNS-30-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">JNS-30-0-s001.docx</a><sup> (66.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p"><p>
<strong>Supplementary Table 3:</strong> Physician reported overall satisfaction with, and perceived level of symptom control on, current drug treatment, and split by region/country.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12361836/bin/JNS-30-0-s004.docx" data-ga-action="click_feat_suppl" class="usa-link">JNS-30-0-s004.docx</a><sup> (61.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p"><p>
<strong>Supplementary Table 4:</strong> Healthcare resource utilization split by region/country.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12361836/bin/JNS-30-0-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">JNS-30-0-s002.docx</a><sup> (76.3KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of the Peripheral Nervous System are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/jns.70047"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/JNS-30-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12361836/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12361836/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12361836%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361836/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12361836/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12361836/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40826893/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12361836/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40826893/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12361836/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12361836/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="VXaBDk3roZq0FV0LLMbkWdoIWucDfjDnQGCMK9iYaTpUBaKVPa3ZZvgXFhvN06Z5">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
